CVE-2024-47885

astro's client-side router has DOM Clobbering Gadget that leads to XSS

Description

The Astro web framework has a DOM Clobbering gadget in the client-side router starting in version 3.0.0 and prior to version 4.16.1. It can lead to cross-site scripting (XSS) in websites enables Astro's client-side routing and has *stored* attacker-controlled scriptless HTML elements (i.e., `iframe` tags with unsanitized `name` attributes) on the destination pages. This vulnerability can result in cross-site scripting (XSS) attacks on websites that built with Astro that enable the client-side routing with `ViewTransitions` and store the user-inserted scriptless HTML tags without properly sanitizing the `name` attributes on the page. Version 4.16.1 contains a patch for this issue.

Category

5.9
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.02%
Affected: withastro astro
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2024-47885?
CVE-2024-47885 has been scored as a medium severity vulnerability.
How to fix CVE-2024-47885?
To fix CVE-2024-47885, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2024-47885 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2024-47885 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-47885?
CVE-2024-47885 affects withastro astro.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.